Biopharma's Top Offshore Destinations

Pharmaceutical Executive

Biopharmaceutical manufacturing is following the general pharmaceutical market trend toward global expansion.

Biopharmaceutical manufacturing is following the general pharmaceutical market trend toward global expansion.

BioPlan Associates’ 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production identifies the markets best poised to profit from the internationalization of the outsourcing, finding that emerging markets such as China and India are among top potential destinations for both US and Western European companies.

As part of the study, respondents were asked to consider their five-year time horizon (lead-up to 2019) and to evaluate their facility’s current plans for future international capacity expansion (not domestic).

More than 25 countries as potential outsourcing destinations, and geographic proximity is no longer seen as a critical factor in the partner selection process.

For more on this Pharm Tech article by Eric Langer, click here.